Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism

Cancer Cell(2021)10.1016/j.ccell.2021.02.006Source: DataRank Database

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 3.15)OA: bronzeTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Rajni Kumari ORCID,Emily Schwenger ORCID,Justin C. Wheat ORCID,Oliver Bohorquez ORCID,Swathi-Rao Narayanagari ORCID

Live enrichment

PubMed:33667384 PMC:PMC8575661 OpenAlex:https://openalex.org/W3133950868

New York State Stem Cell Science

Grant: C029154

National Institutes of Health

Grant: R01CA217092

National Institutes of Health

Grant: R01HL150832

National Institutes of Health

Grant: R01HL139487

National Institutes of Health

Grant: CA47296

NCI NIH HHS

Grant: P30 CA013330

NIGMS NIH HHS

Grant: T32 GM007288

NCI NIH HHS

Grant: R01 CA047296

NIGMS NIH HHS

Grant: F30 GM122308

NIH

FWCI

3.15

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S1535610821001082/pdf

publisherhttp://www.cell.com/article/S1535610821001082/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821001082?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821001082?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2021.02.006

Fields of Study

Acute Myeloid Leukemia ResearchEpigenetics and DNA MethylationProtein Degradation and Inhibitors

MeSH Terms

AnimalsHumansMyelodysplastic SyndromesProto-Oncogene ProteinsLeukemia, Myeloid, AcuteCell Cycle ProteinsProteomicsCell Line, Tumorbeta CateninMiceWnt Signaling Pathway

Keywords

MDMXWnt signaling pathwayMyeloid leukemiaCancer researchMyelodysplastic syndromesLeukemiaBiologyCancerSignal transductionImmunologyCell biologySuppressorGeneticsBone marrowAcute myeloid leukemiaTargeted TherapyΒ-cateninPreleukemiaCk1αPreleukemic Stem CellsPrecision PreventionCancer Interception

Sustainable Development Goals

SDG 0: Good health and well-being

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism

FAIR Checklist

Authors (23)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)